SEC Form 4 · accession 0001104659-16-140889
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Shannon
Officer — President & CEO · Director
Period of report
Aug 18, 2016
Accepted (ET)
Aug 22, 2016 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2016 | M | 120,000 | $2.94 | A | 120,000 | D | |
| Common Stock | Aug 18, 2016 | F | 6,867 | $51.38 | D | 113,133 | D | |
| Common StockF2 | Aug 18, 2016 | S | 10,822 | $51.76 | D | 102,311 | D | |
| Common StockF3 | Aug 19, 2016 | S | 19,694 | $51.40 | D | 82,617 | D | |
| Common StockF4 | Aug 22, 2016 | S | 82,617 | $51.58 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $2.94 | Aug 18, 2016 | M | 120,000 | D | — | Dec 21, 2017 | Common Stock | 120,000 | 124,637 | D |
Explanation of responses
- F1Represents shares of common stock withheld in payment of the exercise price of options.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $51.40 to $52.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $51.40 to $51.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $51.40 to $52.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F5The options vested on September 23, 2013.